Quantum Chemistry Methods for Oncological Drugs
- 1st Edition - February 29, 2024
- Author: Eudenilson L. Albuquerque
- Language: English
- Paperback ISBN:9 7 8 - 0 - 4 4 3 - 1 5 5 3 0 - 7
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 1 5 5 3 1 - 4
Quantum Chemistry Methods for Oncological Drugs provides a comprehensive reference text for student, researchers, and academic staff across disciplines working in the field of… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteQuantum Chemistry Methods for Oncological Drugs provides a comprehensive reference text for student, researchers, and academic staff across disciplines working in the field of Nanobiotechnology, who need to grasp the unique inter-relationship of the physical, chemical, and biological properties of oncological drugs and their interactions. It provides a theoretical/computational framework based on quantum chemistry and addresses key questions in which detailed analysis and precise predictions are always required.
The sophisticated molecular recognition of various natural biological materials has been used in the formation of a complex network of structures potentially useful for a variety of pharmaceutical applications. They offer solutions to many of the obstacles that need to be overcome, with accuracy not feasible with the technologies usually available in materials science. Important common challenges presented in this book are aspects related to the biology of cancer using our immunological checking points, specialized proteins that act as brakes in the immune system, allowing it to recognize and attack more efficiently only the cancer cells, avoiding the destruction of healthy cells as in conventional chemotherapy and radiotherapy treatments.
This book is devoted to this burgeoning area of Nanobiotechnology for oncological drugs and will be valuable in covering the new developments that have occurred in the last decade or so. It is aimed at graduate students, faculty members and other researchers in physics, chemistry, biology, pharmacology, and medicine.
- Comprehensive and up-to-date account of the main physical, chemical, biological, and pharmaceutical properties of oncological drugs and their interactions, using a theoretical/computational framework based on quantum chemistry
- Focuses on an exciting and dynamic area of research, not only in the academic world but also in the Nanobiotechnology industry
- Strong multidisciplinary content: the immediate future of pure and applied scientific research undoubtedly points to the interconnection and complementarity between different areas
Graduate students, faculty members and other researchers in physics, chemistry, biology, pharmacology, and medicine. It will be useful in providing instructional material in these areas, as a review of the field of study, and/or as a comprehensive reference. It is not primarily intended as a course textbook, but it could be used as such for graduate level courses on specialized topics in related areas
- Cover image
- Title page
- Table of Contents
- Copyright
- Dedication
- Preface
- Part I: Quantum chemistry: A review
- 1. From classical to quantum physics
- Abstract
- 1.1 Classical physics
- 1.2 Failures of classical physics
- 1.3 The old quantum theory
- 1.4 Conclusions
- References
- 2. Main theoretical results
- Abstract
- 2.1 Introduction
- 2.2 Lagrangian mechanics
- 2.3 Hamiltonian mechanics
- 2.4 Schrödinger equation
- 2.5 The postulates of quantum mechanics
- 2.6 The electronic spin angular momentum
- 2.7 Perturbation theory
- 2.8 Conclusions
- References
- 3. Computational approach
- Abstract
- 3.1 Introduction
- 3.2 Chemical bonds
- 3.3 Born–Oppenheimer approximation
- 3.4 Many-particle systems
- 3.5 Density functional theory
- 3.6 Kohn–Sham approach
- 3.7 Exchange-correlation functionals
- 3.8 Molecular fractional with conjugate caps method
- 3.9 Conclusions
- References
- Part II: Immune-oncological drugs
- 4. Cancer immunotherapy
- Abstract
- 4.1 Introduction
- 4.2 The human immune system
- 4.3 The immune checkpoint proteins
- 4.4 Main immune-oncological drugs
- 4.5 Conclusions
- References
- 5. Immune-oncological drug atezolizumab
- Abstract
- 5.1 Introduction
- 5.2 Materials and methods
- 5.3 Main results and discussions
- 5.4 Conclusions
- References
- 6. Immune-oncological drug nivolumab
- Abstract
- 6.1 Introduction
- 6.2 Materials and methods
- 6.3 Main results and discussions
- 6.4 Conclusions
- References
- 7. Immune-oncological drug pembrolizumab
- Abstract
- 7.1 Introduction
- 7.2 Materials and methods
- 7.3 Main results and discussions
- 7.4 Conclusions
- References
- 8. Immune-oncological drug ipilimumab
- Abstract
- 8.1 Introduction
- 8.2 Materials and methods
- 8.3 Main results and discussions
- 8.4 Conclusions
- References
- 9. Optoelectronics properties
- Abstract
- 9.1 Introduction
- 9.2 Materials and methods
- 9.3 Main results and discussions
- 9.4 Conclusions
- References
- Part III: Transverse oncological drugs
- 10. Oncological treatment
- Abstract
- 10.1 Introduction
- 10.2 Computational quantum chemistry as a therapeutic alternative
- 10.3 Conclusions
- References
- 11. Oncological drugs complexed with the human serum albumin
- Abstract
- 11.1 Introduction
- 11.2 Materials and methods
- 11.3 Main results and discussions
- 11.4 Conclusions
- References
- 12. Antibreast cancer oncological drugs
- Abstract
- 12.1 Introduction
- 12.2 Materials and methods
- 12.3 Main results and discussions
- 12.4 Conclusions
- References
- 13. Antiprostate cancer oncological drugs
- Abstract
- 13.1 Introduction
- 13.2 Materials and methods
- 13.3 Main results and discussions
- 13.4 Conclusions
- References
- Part IV: Looking ahead
- 14. The future of the oncological treatment
- Abstract
- 14.1 Introduction
- 14.2 The cancer biology
- 14.3 Some open questions
- 14.4 Conclusions
- References
- Index
- No. of pages: 302
- Language: English
- Edition: 1
- Published: February 29, 2024
- Imprint: Elsevier Science
- Paperback ISBN: 9780443155307
- eBook ISBN: 9780443155314
EA